Within the process of asthma pathogenesis, the IL-33/ST2 axis is known to drive mast cell activation, resulting in the release of pro-allergic cytokines and chemokines that exacerbate airway hyperresponsiveness 13,58-59. This evidence concerns the gene IL33 and airway hyperresponsiveness.